Taking Wegovy Every 10 Days for Weight Loss: What the Licensed Schedule Actually Says

The decision you're probably weighing: flexibility versus the licensed regimen

It is a reasonable question. Life gets in the way of weekly schedules, travel, a busy patch at work, simply forgetting. The thought of stretching doses out a little to recapture one that slipped can feel logical. The difficulty is that semaglutide does not work like a supplement you can take when it suits you; it maintains a particular concentration in your body across the week, and that steady presence is what underpins the appetite reduction and metabolic effects that produce weight loss.

The STEP 1 trial (the large phase-3 study published in the New England Journal of Medicine that supported Wegovy's approval) ran on a strict once-weekly protocol. When the data say participants achieved around 15% average weight loss over 68 weeks, that figure comes from people injecting on schedule, not on an improvised timetable. A 10-day interval is simply a different regimen, one for which there is no clinical evidence in this context.

So the real decision is not "every 7 days versus every 10", it is "what is making weekly dosing feel difficult, and is there a practical solution?" The sections below work through the factors that are worth considering before arriving at a consultation.

What actually happens if a dose is late or missed

The Patient Information Leaflet sets out the official missed-dose guidance: if fewer than five days have passed since your usual injection day, take the dose as soon as you remember; if five or more days have passed, skip that dose and return to your normal weekly schedule the following week. The NHS semaglutide page echoes this clearly.

What the leaflet does not say is to inject every 10 days as a standing arrangement. An occasional late dose, managed per the leaflet, is a different matter from deciding routinely to extend the interval. A habitual 10-day cycle would mean fewer doses per year, lower average drug exposure, and (in all likelihood) reduced effectiveness compared with the regimen that produced the trial results.

There is also a practical side. Semaglutide levels drop off between doses; some people already notice increased appetite in the day or two before their next injection. Stretching that gap by three days is likely to make that window more pronounced, not less.

One quick thing worth doing before your next injection: check the day and time of your last dose against your phone's calendar or the pen's label, it takes under a minute and makes it easier to confirm you are on schedule, or to flag a genuine delay to your prescriber.

Alternatives worth raising with a prescriber if the injection schedule is genuinely difficult

There are real situations where the weekly injection is a challenge: a demanding travel schedule, needle anxiety, a condition that makes self-injection harder. None of those are reasons to modify the regimen silently, they are reasons to talk to a prescriber, because options exist.

The most significant development as of summer 2026 is the MHRA's approval of the Wegovy tablet, the oral form of semaglutide, taken once daily rather than once weekly. It suits people who prefer not to inject, and the once-daily habit can feel more natural for some. The cost context is different from the injection; you can read about that on our Wegovy cost page.

For the injection itself, choosing a consistent day that genuinely fits your week helps, Sunday evening while the week is fresh in your mind, or Friday as a marker of the week's end. If it is needle anxiety rather than timing, that is a conversation our clinical team hear regularly, and there are practical techniques that help most people settle into the routine within the first month.

How eligibility and suitability for Wegovy are assessed at the outset

Before the question of interval arises, a prescriber must first confirm that Wegovy is suitable at all. The UK licence covers adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, raised cholesterol or sleep apnoea. Lower BMI thresholds apply for certain ethnic backgrounds under UK guidance. The BMI requirements for Wegovy are explained in detail separately.

A prescriber also looks at the wider picture: other medicines you take, your medical history, whether you are pregnant, trying to conceive, or breastfeeding (semaglutide is not recommended in those situations). Wegovy is not licensed for anyone under 18. The full eligibility criteria cover this more thoroughly if you want to check your situation before booking.

If you have already started Wegovy elsewhere and are considering transferring, or if you have questions about whether a schedule change is medically justified for your circumstances, a fresh clinical review is the right step. If you are still at the stage of wondering whether you can get Wegovy for weight loss and what that process looks like, that page walks through the key questions in plain terms. You can also explore whether Wegovy is the right fit compared with other licensed options by reading about whether Wegovy is the right treatment for you. When you are ready, check your eligibility with our prescribers, the consultation is free, and a clinician reviews every application the same day.